With a highly competitive environment and low barriers to entry, the toy industry continues to offer challenges, even for big household names like Hasbro (NASDAQ:
Annual Holiday Shopping Event Kicks Off on October 7 with Amazing Early-bird Deals; Ends October 14
Groupon's survey data shows that over 80% of consumers plan to spend more on experience-related gifts
Event is taking place on Thursday, October 6th at 11:30 a.m. ET
Event will feature a presentation by key opinion leader, Kevin L. Winthrop, MD, MPH (Division of Infectious Disease, OHSU Medical
Aura Biosciences Inc. (NASDAQ:AURA), a clinical-stage biotechnology company developing a novel class of virus-like drug conjugate (VDC) therapies for multiple oncology indications, today announced that interim Phase 2
BioCardia®, Inc. (NASDAQ:BCDA), a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announces data from its FDA designated Breakthrough
Cytokinetics, Incorporated (Nasdaq: CYTK) today announced new data on symptom improvement and quality of life related to treatment with aficamten in REDWOOD-HCM OLE (Randomized Evaluation of Dosing With CK-274 in Obstructive Outflow Disease in HCM Open Label Extension) in a Late Breaking Clinical Trials session at the Heart Fa
The two-year U.S. treasury yield reached 4.167% on Friday. The 10-year U.S. treasury yield hit 3.762%. This allows the yield curve to remain in an inverse relationship, which typically points to a recession.
New ex vivo data demonstrates protection against cyclophosphamide-induced damage to hair follicles and their stem cells
Encore presentation of data presented at Society for Investigative Dermatology in May